38112003: 1 (kwalificatiewaarde)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
1 (kwalificatiewaarde)	Is a	General adjectival modifier	false	Inferred relationship	Some
1 (kwalificatiewaarde)	Is a	Number	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Fentanyl 300 microgram buccal tablet	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Fentanyl 300 microgram buccal tablet	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Alcaftadine 2.5 mg/mL eye solution	Has concentration strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Alcaftadine 2.5 mg/mL eye solution	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely risperidone 500 microgram/1 each conventional release orodispersible tablet (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely risperidone 500 microgram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Risperidone 4 mg orodispersible tablet	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Risperidone 4 mg orodispersible tablet	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely nepafenac 1 milligram/1 milliliter conventional release eye suspension (clinical drug)	Has concentration strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely nepafenac 1 milligram/1 milliliter conventional release eye suspension (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely nepafenac 1 milligram/1 milliliter conventional release eye suspension (clinical drug)	Has concentration strength numerator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/g eye ointment	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/g eye ointment	Has concentration strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing only mirtazapine in oromucosal dose form (medicinal product form)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Tobramycin 3 mg/g eye ointment	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Tobramycin 3 mg/g eye ointment	Has concentration strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Fentanyl 400 microgram buccal film	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Fentanyl 400 microgram buccal film	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing only paliperidone in oral dose form (medicinal product form)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Hydrocortisone 10 mg/mL eye solution	Has concentration strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Hydrocortisone 10 mg/mL eye solution	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Memantine hydrochloride 28 mg prolonged-release oral capsule	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Memantine hydrochloride 28 mg prolonged-release oral capsule	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely zinc sulfate 220 milligram/1 each conventional release effervescent oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely zinc sulfate 220 milligram/1 each conventional release effervescent oral tablet (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Aspirin 81 mg gastro-resistant oral tablet	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Aspirin 81 mg gastro-resistant oral tablet	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug)	Has concentration strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Unoprostone isopropyl 1.5 mg/mL eye solution	Has concentration strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Unoprostone isopropyl 1.5 mg/mL eye solution	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Propamidine isetionate 1.5 mg/g eye ointment	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Propamidine isetionate 1.5 mg/g eye ointment	Has concentration strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely estradiol 2.083 microgram/1 hour prolonged-release vaginal ring (clinical drug)	Has concentration strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely estradiol 2.083 microgram/1 hour prolonged-release vaginal ring (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely hydromorphone hydrochloride 3 milligram/1 each conventional release rectal suppository (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely hydromorphone hydrochloride 3 milligram/1 each conventional release rectal suppository (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely pentobarbital sodium 60 milligram/1 each conventional release rectal suppository (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely pentobarbital sodium 60 milligram/1 each conventional release rectal suppository (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Tioconazole 65 mg/g vaginal ointment	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Tioconazole 65 mg/g vaginal ointment	Has concentration strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Colestipol hydrochloride 5 g granules for oral suspension sachet	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Colestipol hydrochloride 5 g granules for oral suspension sachet	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Metformin hydrochloride 500 mg and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Metformin hydrochloride 500 mg and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	2
Product containing precisely trazodone hydrochloride 300 milligram/1 each prolonged-release oral tablet (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely trazodone hydrochloride 300 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely fentanyl 600 microgram/1 each conventional release buccal film (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely fentanyl 600 microgram/1 each conventional release buccal film (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment	Has concentration strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	2
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment	Has concentration strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely ranitidine (as ranitidine hydrochloride) 25 milligram/1 each conventional release effervescent oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely ranitidine (as ranitidine hydrochloride) 25 milligram/1 each conventional release effervescent oral tablet (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing only risperidone in oromucosal dose form (medicinal product form)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Sulfafurazole 40 mg/mL eye solution	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Sulfafurazole 40 mg/mL eye solution	Has concentration strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Belladonna alkaloid 16.2 mg and opium 60 mg rectal suppository	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Belladonna alkaloid 16.2 mg and opium 60 mg rectal suppository	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	2
Hydrocortisone acetate 25 mg rectal suppository	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Hydrocortisone acetate 25 mg rectal suppository	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Magnesium salicylate 580 mg oral tablet	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Magnesium salicylate 580 mg oral tablet	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely bromfenac (as bromfenac sodium) 900 microgram/1 milliliter conventional release eye solution (clinical drug)	Has concentration strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely bromfenac (as bromfenac sodium) 900 microgram/1 milliliter conventional release eye solution (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing only linaclotide in oral dose form (medicinal product form)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely paliperidone 1.5 milligram/1 each prolonged-release oral tablet (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely paliperidone 1.5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug)	Has concentration strength numerator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	2
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug)	Has concentration strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	2
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug)	Has concentration strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Droxidopa 100 mg oral capsule	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Droxidopa 100 mg oral capsule	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely pentobarbital sodium 120 milligram/1 each conventional release rectal suppository (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely pentobarbital sodium 120 milligram/1 each conventional release rectal suppository (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	3
Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	2
Dexamethasone 500 microgram/mL and tobramycin 3 mg/mL eye suspension	Has concentration strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Dexamethasone 500 microgram/mL and tobramycin 3 mg/mL eye suspension	Has concentration strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	2
Estradiol 4.167 microgram/hour prolonged-release vaginal ring	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Estradiol 4.167 microgram/hour prolonged-release vaginal ring	Has concentration strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely brimonidine tartrate 1 milligram/1 milliliter conventional release eye solution (clinical drug)	Has concentration strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely brimonidine tartrate 1 milligram/1 milliliter conventional release eye solution (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely brimonidine tartrate 1 milligram/1 milliliter conventional release eye solution (clinical drug)	Has concentration strength numerator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely fampridine 10 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely fampridine 10 milligram/1 each prolonged-release oral tablet (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Ropinirole (as ropinirole hydrochloride) 4 mg prolonged-release oral tablet	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Ropinirole (as ropinirole hydrochloride) 4 mg prolonged-release oral tablet	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Linaclotide 145 microgram oral capsule	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Linaclotide 145 microgram oral capsule	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely glyceryl trinitrate 3 milligram/1 each conventional release buccal tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely glyceryl trinitrate 3 milligram/1 each conventional release buccal tablet (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely pilocarpine hydrochloride 100 milligram/1 milliliter conventional release eye solution (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely pilocarpine hydrochloride 100 milligram/1 milliliter conventional release eye solution (clinical drug)	Has concentration strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Ibuprofen 50 mg chewable tablet	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Ibuprofen 50 mg chewable tablet	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely deferasirox 500 milligram/1 each tablet for conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some

Start Previous Page 173 of 215 Next End

Reference Sets

Concept inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
64719019	One	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442104013	1 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442105014	1	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
12718871000146116	1 (kwalificatiewaarde)	nl	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Netherlands NRC maintained module (core metadata concept)
12718881000146119	één	nl	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Netherlands NRC maintained module (core metadata concept)
13856651000146112	1	nl	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Netherlands NRC maintained module (core metadata concept)